ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,768Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 546

$547K Total Retail Price of All Prescriptions

Rank: 44 out of 546

498 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 6,980 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LISINOPRIL 890 468 1 1
METOPROLOL TARTRATE 452 318 2 6
FUROSEMIDE 439 299 3 5
LOVASTATIN 365 241 4 22
OMEPRAZOLE 360 177 5 4
SIMVASTATIN 344 171 6 2
HYDROCHLOROTHIAZIDE 328 220 7 7
HYDROCODONE-ACETAMINOPHEN 296 106 S3 8 8
AMLODIPINE BESYLATE 270 190 9 9
GLIPIZIDE 259 150 10 44
ATENOLOL 241 162 11 12
RANITIDINE HCL 240 123 12 23
METFORMIN HCL 222 138 13 10
KLOR-CON M20 222 148 13 57
CYCLOBENZAPRINE HCL 201 37 R 15 34
LEVOTHYROXINE SODIUM 193 98 16 3
ADVAIR DISKUS 176 91 17 20
TRAZODONE HCL 174 55 18 25
PAROXETINE HCL 163 129 19 43
PREDNISONE 163 76 19 29
INSULIN SYRINGE 156 70 21 85
GABAPENTIN 153 62 22 16
MELOXICAM 138 70 23 58
WARFARIN SODIUM 122 35 24 13
TAMSULOSIN HCL 119 96 25 35
PROAIR HFA 111 64 26 27
PANTOPRAZOLE SODIUM 109 53 27 18
GLYBURIDE 107 61 R 28 45
VENTOLIN HFA 107 65 28 63
ISOSORBIDE MONONITRATE ER 104 77 30 32
SERTRALINE HCL 94 49 31 14
OXYBUTYNIN CHLORIDE 93 59 32 106
ALLOPURINOL 92 45 33 41
ATORVASTATIN CALCIUM 90 60 34 11
AMITRIPTYLINE HCL 88 41 R 35 48
CLONIDINE HCL 85 55 36 115
LANTUS 85 37 36 46
CLOPIDOGREL 82 47 38 77
SPIRIVA 78 36 39 28
HYDROXYZINE PAMOATE 77 17 R 40 153
DILTIAZEM 24HR CD 77 73 40 91
CITALOPRAM HBR 76 0 42 21
TRAMADOL HCL 75 25 43 19
FLUOXETINE HCL 73 32 44 39
FLUTICASONE PROPIONATE 71 23 45 42
PLAVIX 70 54 46 116
JANTOVEN 69 61 47 92
OXYCODONE HCL 66 24 S2 48 15
BACLOFEN 66 23 48 86
LYRICA 66 13 48 69
ROPINIROLE HCL 65 0 51 64
DILTIAZEM ER 64 50 52 123
COMBIVENT 64 48 52 71
MECLIZINE HCL 62 33 54 131
CLEMASTINE FUMARATE 61 48 R 55 225
SINGULAIR 61 28 55 136
NIFEDIPINE ER 56 39 57 193
NITROSTAT 56 27 57 132
IBUPROFEN 55 18 59 70
NAPROXEN 54 24 60 107
OXYCODONE-ACETAMINOPHEN 54 29 S2 60 54
POTASSIUM CHLORIDE 54 31 60 30
PRAMIPEXOLE DIHYDROCHLORIDE 53 23 63 149
BUSPIRONE HCL 52 14 64 146
MONTELUKAST SODIUM 52 23 64 240
KLOR-CON 10 51 44 66 133
DICLOFENAC SODIUM 51 18 66 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.